Chemotherapy-induced Symptoms in Sarcoma Patients and the Impact of Tumor Burden
Time Perspective: Prospective
To determine the extent of symptom burden and quality of life in sarcoma patients receiving AI chemotherapy.
Hussein Tawbi, MD
University of Pittsburgh
United States: Food and Drug Administration
|University of Pittsburgh, Hillman Cancer Center||Pittsburgh, Pennsylvania 15232|